Trump administration has approved A general version of abortion pill mifaprystone, Health Secretary Robert F. Kennedy ordered to review the drug safety despite Junior.
Medication will now be produced Evita Solutions by LLC, which describes its mission as “to normalize” Abortion“And make it” accessible to all “. The company received approval Faka On Tuesday.
“We have completed this ea review [abbreviated new drug application] And concluded that enough information is presented to showcase it Drug meets requirements for approval Under the FD & C Act, “FDA wrote.” Accordingly, the Enda has been approved. ,
Susan b. Anthony Pro-Life America President Marjori Dannnafalesar described the “careless” decision by the FDA, which was as “unconscious” to expand the availability of abortion drugs.
Dannafalesar said in a statement on Thursday, “These dangerous drugs take the lives of unborn children, put women at serious risk and put girls at serious risk, empowering abusers, and pro -life -made by the states across the country trample laws.”
Dozens of colleagues-reviewed studies have found that less than 0.5 percent of patients who take mifepristone have severe adverse reactions, and have been approved by the FDA and have been widely used for more than 20 years.
However, earlier this year, A suspicious report from anti-abortion activists Attempted to suspect the safety of the drug.
In the report, the Ethics and Public Policy Center, a right -wing think tank, claimed that serious complications from the use of mifaprystone were 22 times more than the report and the FDA was called to “fully reconsider its approval”.
Despite the report that miscarriage pro -abortion advocates and public health authorities being unscientific and politically motivated by Kennedy and Trump, FDA Commissioner, Marti Makiri, have said that they will re -organize the safety of Mifiprystone.
Maki had said that earlier he had no plans to change the government’s position on Mifaprystone until the new data discovered security concern.
Missouri Republican Sen. Josh HaleWhose wife, Erin Hale, who is a senior lawyer with the freedom to defend the right -wing legal advocacy group coalition, was one of those who called Makari to “follow this new data”.
Haley expressed displeasure after the announcement of the FDA’s decision on Thursday, described it as a “shocking”.
“The FDA has approved only another chemical abortion drug, when evidence suggests that chemical abortion drugs are dangerous and even fatal to the mother. And of course 100% fatal to the child,” he wrote.
“The FDA promised to review a top-to-back security of chemical miscarriage drug, but instead they have kept its new versions in green for distribution. I have lost confidence in the leadership in the FDA.”
.jpg)
Meanwhile, on Wednesday, the anti-miscarriage District Judge Matthew Ksmeric-The court ruled on Mifepristone, began a Supreme Court’s fight-decided to transfer a case that challenged the FDA drug approval in a court in Missouri, which has been packed with Trump appointments.
“We are disappointed that the court failed to rule to dismiss our proposal today, allowing this politically motivated case to move forward,” said Ivan Masingil, CEO of the company JenbioPro at the center of the case, which is also approved for the manufacture of drug.
“Mifaprystone has been approved by the FDA for a fourth century using its harsh standards. Any attempt to refund access to the violation of mifepristone on the reproductive freedom of Americans will endanger any attempt and nationwide millions of people.
“Genbiopro is committed to ensuring inexpensive, science-based access to the drug abortion for all, which require it.”